WASHINGTON — The only evidence-based therapy for neonatal encephalopathy is not effective for younger newborns, researchers reported at the Pediatric Academic Societies Meeting.
According to a new study, therapeutic hypothermia, the sole evidence-based treatment for neonates born with neonatal encephalopathy (NE) at or after 36 weeks, is ineffective for lowering death or moderate/severe damage in newborns born between 33 and 35 weeks.
Therapeutic hypothermia, the only evidence-based treatment for newborns born with neonatal encephalopathy (NE) at or after 36 weeks, is not effective for reducing death or moderate/severe disability in newborns born between 33 and 35 weeks, according to a new study.